chr12-8861187-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_144670.6(A2ML1):c.3392C>T(p.Thr1131Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00342 in 1,614,122 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_144670.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
A2ML1 | NM_144670.6 | c.3392C>T | p.Thr1131Met | missense_variant | 28/36 | ENST00000299698.12 | NP_653271.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
A2ML1 | ENST00000299698.12 | c.3392C>T | p.Thr1131Met | missense_variant | 28/36 | 1 | NM_144670.6 | ENSP00000299698.7 | ||
A2ML1 | ENST00000541459.5 | c.2042C>T | p.Thr681Met | missense_variant | 17/25 | 2 | ENSP00000443174.1 | |||
A2ML1 | ENST00000539547.5 | c.1919C>T | p.Thr640Met | missense_variant | 17/25 | 2 | ENSP00000438292.1 | |||
ENSG00000282022 | ENST00000631830.1 | n.322-2911G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0124 AC: 1891AN: 152124Hom.: 42 Cov.: 32
GnomAD3 exomes AF: 0.00367 AC: 917AN: 249544Hom.: 16 AF XY: 0.00293 AC XY: 396AN XY: 135382
GnomAD4 exome AF: 0.00248 AC: 3622AN: 1461880Hom.: 46 Cov.: 32 AF XY: 0.00223 AC XY: 1621AN XY: 727244
GnomAD4 genome AF: 0.0125 AC: 1896AN: 152242Hom.: 43 Cov.: 32 AF XY: 0.0123 AC XY: 917AN XY: 74454
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 30, 2019 | Variant summary: A2ML1 c.3392C>T (p.Thr1131Met) results in a non-conservative amino acid change located in the Alpha-macroglobulin like TET domain (IPRO11626) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0037 in 249544 control chromosomes in the gnomAD database, including 16 homozygotes. The observed variant frequency is approximately 919 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3392C>T in individuals affected with Noonan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at